Patient Guide: DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06539195
Status: 🟢 Enrolling Now
Condition: Diffuse Large B Cell Lymphoma
Phase: PHASE2

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Hefei, Anhui
  • • Beijing, Beijing
  • • Guangzhou, Guangdong
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9) - Join Clinical Trial NCTNCT06539195

How to Join This Clinical Trial - NCTNCT06539195

Learn how to participate in this PHASE2 trial studying an investigational therapy for Diffuse Large B Cell Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diffuse Large B Cell Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diffuse Large B Cell Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06539195 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230031 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing 100083 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510060 - China

Status: RECRUITING

Clinical Research Site

Nanning, Guangxi 530016 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 450003 - China

Status: RECRUITING

Clinical Research Site

Wuhan, Hubei 430023 - China

Status: RECRUITING

Clinical Research Site

Changsha, Hunan 410031 - China

Status: RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210009 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Dalian, Liaoning 116021 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Jinan, Shandong 250117 - China

Status: RECRUITING

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Diffuse Large B Cell Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships